This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Dalhousie University directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420.
medRxiv : the preprint server for health sciences · 2026
Pathological investigation and microbiological confirmation of Bartonella quintana endocarditis: A case of trench fever without the trench or fever.
IDCases · 2025
Quadrivalent HPV Vaccine Evaluation Study with Addition of the Nonavalent Vaccine (QUEST-ADVANCE): protocol of an observational cohort study.
BMJ open · 2025
Latest funding
Canadian Immunization Research Network (CIRN) Renewal
CIHR · 2024 · Principal investigator
- $4,569,190
Open-label, phase 1/2, dose-escalation and dose-confirmation clinical trial to establish a Controlled Human Infection Model (CHIM) by determining and confirming the optimal, safe, and reproducible Influenza A:H3N2 dose administered intranasally to healthy adults 18-40 years of age that induces mild symptomatic infection and detection of Influenza A:H3N2 in nasal secretions by culture and/or PCR
CIHR · 2023 · Co-investigator
- $1,142,297
Open-label, phase 1/2, dose-escalation and dose-confirmation clinical trial to establish a Controlled Human Infection Model (CHIM) by determining and confirming the optimal, safe, and reproducible Influenza A:H3N2 dose administered intranasally to healthy adults 18-40 years of age that induces mild symptomatic infection and detection of Influenza A:H3N2 in nasal secretions by culture and/or PCR
CIHR · 2023 · Co-investigator
44 publications.
A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420.
ElSherif MS, Redden KL, Langley JM, Ye L, Blanchard W, Smith B, Wang J, Abu-Raya B, Filliter JH, Edwards KM, Creech CB, McNeil S, Hatchette TF, LeBlanc JJ, Hariri S, Pawloski L, Maniatis P, Fox LM, Whittle CA, Halperin SA
Pathological investigation and microbiological confirmation of Bartonella quintana endocarditis: A case of trench fever without the trench or fever.
Grace N, LeBlanc JJ, Boodman C, Lindsay R, Dibernardo A, Loomer C, Coatsworth H, Bernard KA, McCracken GR, McNeil S, Castonguay M, Patriquin G
Quadrivalent HPV Vaccine Evaluation Study with Addition of the Nonavalent Vaccine (QUEST-ADVANCE): protocol of an observational cohort study.
Middeldorp M, Donken R, Nirmal A, Smith B, Citlali Marquez A, Bettinger JA, Brisson M, Burchell AN, Dobson SR, Dawar M, Franco EL, Grennan T, Krajden M, Mayrand MH, McNeil S, Naus M, Sauvageau C, Singer J, Smith LW, Ogilvie GS, Sadarangani M
The Global Influenza Hospital Surveillance Network: A Multicountry Public Health Collaboration.
Nunes MC, Chauvel C, Raboni SM, López-Labrador FX, Andrew MK, Badar N, Baillie V, Bal A, Baral K, Baumeister E, Boutros C, Burtseva E, Coulibaly D, Cowling B, Danilenko D, Dbaibo G, Destras G, Dia N, Drăgănescu AC, Giamberardino HIG, Gomez-Camargo D, Josset L, Koul PA, Kyncl J, Laguna-Torres VA, Launay O, Nugyen LBL, McNeil S, Medić S, Mira-Iglesias A, Mironenko A, Nitsch-Osuch A, Orrico-Sánchez A, Otieno NA, Regue H, Ruiz-Palacios GM, Salah AB, Salman M, Săndulescu O, Simon V, Sominina A, Sordillo E, Tanriover MD, Unal S, van Bakel H, Vanhems P, Zhang T, Commaille-Chapus C, Hunsinger C, Bresee J, Lina B, McCauley JW, Ortiz JR, Viboud C, Zhang W, Torcel-Pagnon L, Mahe C, Chaves SS
Assessing a safety climate tool adapted to address respiratory illnesses in Canadian hospitals
Jiang L, Muller M, McGeer A, Simor A, Holness DL, Coleman KKL, Katz K, Loeb M, McNeil S, Nichol K
An enveloped virus-like particle alum-adjuvanted cytomegalovirus vaccine is safe and immunogenic: A first-in-humans Canadian Immunization Research Network (CIRN) study.
Langley JM, Gantt S, Halperin SA, Ward B, McNeil S, Ye L, Cai Y, Smith B, Anderson DE, Mitoma FD
Influenza vaccine coverage and factors associated with non-vaccination among adults at high risk for severe outcomes: An analysis of the Canadian Longitudinal Study on Aging.
Gravagna K, Wolfson C, Sulis G, Buchan SA, McNeil S, Andrew MK, McMillan J, Kirkland S, Basta NE
Immunogenicity of 2 and 3 Doses of the Quadrivalent Human Papillomavirus Vaccine up to 120 Months Postvaccination: Follow-up of a Randomized Clinical Trial.
Donken R, Dobson SRM, Marty KD, Cook D, Sauvageau C, Gilca V, Dionne M, McNeil S, Krajden M, Money D, Kellner J, Scheifele DW, Kollmann T, Bettinger JA, Liu S, Singer J, Naus M, Sadarangani M, Ogilvie GS
A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18-50 Years of Age.
Langley J, Pastural E, Halperin S, McNeil S, ElSherif M, MacKinnon-Cameron D, Ye L, Grange C, Thibodeau V, Cailhier JF, Lapointe R, McElhaney J, Martin L, Bolduc M, Laliberté-Gagné ME, Leclerc D, Savard P
Which healthcare workers work with acute respiratory illness? Evidence from Canadian acute-care hospitals during 4 influenza seasons: 2010–2011 to 2013–2014
Jiang L, McGeer A, McNeil S, Katz K, Loeb M, Muller MP, Simor A, Powis J, Kohler P, Di Bella JM
Canadian Immunization Research Network (CIRN) Renewal
Principal investigators: Halperin, Scott A; Andrew, Melissa K; Bettinger, Julie A; Bolotin, Shelly; Brisson, Marc; Buchan, Sarah; Cowan, Juthaporn; Dubé, Eve; Greyson, Devon; Hatchette, Todd F; Heffernan, Jane M; Kwong, Jeffrey C; Langley, Joanne M; MacDonald, Shannon E; McNeil, Shelly A; Muller, Matthew P; Parsons Leigh, Jeanna J; Sadarangani, Manish; Top, Karina A
Keywords: Adverse Events Following Immunization; Immunogenicity; Population-Based Methodology; Rapid Response Research Capacity; Vaccine Coverage; Vaccine Effectiveness; Vaccine Hesitancy; Vaccine Modeling And Economic Analysis; Vaccine Safety; Vulnerable Populations
Open-label, phase 1/2, dose-escalation and dose-confirmation clinical trial to establish a Controlled Human Infection Model (CHIM) by determining and confirming the optimal, safe, and reproducible Influenza A:H3N2 dose administered intranasally to healthy adults 18-40 years of age that induces mild symptomatic infection and detection of Influenza A:H3N2 in nasal secretions by culture and/or PCR
Principal investigators: Halperin, Scott A; Ward, Brian J
Keywords: Challenge Study; Challenge Unit; Controlled Human Infection Model (Chim); Dose-Finding; Dose-Ranging; Healthy Adults; Influenza Virus; Pandemic Preparedness; Phase 1/2 Clinical Trial
Open-label, phase 1/2, dose-escalation and dose-confirmation clinical trial to establish a Controlled Human Infection Model (CHIM) by determining and confirming the optimal, safe, and reproducible Influenza A:H3N2 dose administered intranasally to healthy adults 18-40 years of age that induces mild symptomatic infection and detection of Influenza A:H3N2 in nasal secretions by culture and/or PCR
Principal investigators: Halperin, Scott A; Ward, Brian J
Keywords: Challenge Study; Challenge Unit; Controlled Human Infection Model (Chim); Dose-Finding; Dose-Ranging; Healthy Adults; Influenza Virus; Pandemic Preparedness; Phase 1/2 Clinical Trial
COVID-19 Variant Network - Identification of biomarkers that predict severity of COVID-19 patients
Principal investigators: Kelvin, David J; Andrew, Melissa K; Kelvin, Alyson A; Marshall, Jean S; McNeil, Shelly A
Keywords: Acute Viral Infection; Biomarkers; Severity
Sex as a Biological Variable Supplement - Identification of biomarkers that predict severity of COVID-19 patients
Principal investigators: Kelvin, David J; Andrew, Melissa K; Kelvin, Alyson A; Marshall, Jean S; McNeil, Shelly A
Keywords: Acute Viral Infection; Biomarkers; Severity
Canadian Immunization Research Network: COVID-19 Vaccine Readiness
Principal investigators: Halperin, Scott A; Andrew, Melissa K; Bettinger, Julie A; Bolotin, Shelly; Brisson, Marc; De Serres, Gaston; De Wals, Philippe; Deeks, Shelley L; Dubé, Eve; Hatchette, Todd F; Kellner, James D; Kwong, Jeffrey C; Langley, Joanne M; Loeb, Mark B; MacDonald, Shannon E; McNeil, Shelly A; Top, Karina A; Ward, Brian J
Keywords: Adverse Events Following Immunization; Clinical Trials Capacity And Readiness; Immunogenicity; Knowledge Translation; Population-Based Methodology; Rapid Response Research Capacity; Vaccine Coverage; Vaccine Hesitancy; Vaccine Modeling; Vaccine Safety And Effectiveness
Identification of biomarkers that predict severity of COVID-19 patients
Principal investigators: Kelvin, David J; Andrew, Melissa K; Kelvin, Alyson A; Marshall, Jean S; McNeil, Shelly A
Keywords: Acute Viral Infection; Biomarkers; Severity
Sentinel surveillance, viral shedding, clinical characteristics and outcomes of confirmed and suspected hospitalized cases of COVID-19/SARS-CoV-2 infection in the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance Network
Principal investigators: McNeil, Shelly A
Keywords: Comorbidities; Covid-19 Or Coronavirus; Epidemiology; Frailty; Hospitalization; Outcomes; Respiratory Infection; Surveillance; Testing; Transmission
Canadian Immunization Research Network
Principal investigators: Halperin, Scott A; Andrew, Melissa K; Bettinger, Julie A; Bolotin, Shelly; Brisson, Marc; Burchell, Ann N; Coleman, Brenda L; Crowcroft, Natasha S; De Serres, Gaston; De Wals, Philippe; Deeks, Shelley L; Doroshenko, Alexander; Dubé, Eve; Gagneur, Arnaud A; Kwong, Jeffrey C; Langley, Joanne M; Loeb, Mark B; McNeil, Shelly A; Sadarangani, Manish; Top, Karina A; Ulanova, Marina; Ward, Brian J
Keywords: Adverse Events Following Immunization; Immunogenicity; Population-Based Methodology; Rapid Response Research Capacity; Vaccine Coverage; Vaccine Effectiveness; Vaccine Hesitancy; Vaccine Modeling And Economic Analysis; Vaccine Safety; Vulnerable Populations
A phase 1 Randomized, Single-Centre, Double-Blind, Placebo Controlled, Dose-Ranging Study to Evaluate the Safety and Immunogenicity of the BPSC1001 (VSV¿-ZEBOV) Ebola Virus Vaccine Candidate in Healthy Adult Subjects
Principal investigators: Halperin, Scott A
Keywords: Ebola Virus; Immunogenicity; Placebo Controlled; Safety; Vaccine
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Christina Wolfson and Christina Wolfson: 102 shared papers
- Mark Loeb and Allison McGeer: 39 shared papers
- Mark Loeb and Stephen Walter: 37 shared papers
- Philip Devereaux and Stephen Walter: 28 shared papers
- Mark Loeb and Jonathan Bramson: 26 shared papers
- Mel Krajden and Gina Ogilvie: 21 shared papers
- Allison McGeer and Jennie Johnstone: 21 shared papers
- Mel Krajden and Manish Sadarangani: 15 shared papers
- Allison McGeer and Manish Sadarangani: 15 shared papers
- Deborah Money and Gina Ogilvie: 14 shared papers
- Allison McGeer and Andrew Simor: 12 shared papers
- Deborah Money and Mel Krajden: 10 shared papers
- Mark Loeb and Jennie Johnstone: 9 shared papers
- Christina Wolfson and Jacqueline McMillan: 9 shared papers
- Jacqueline McMillan and Christina Wolfson: 8 shared papers
- Deborah Money and Manish Sadarangani: 7 shared papers
- Mark Loeb and Philip Devereaux: 6 shared papers
- Mark Loeb and Andrew Simor: 6 shared papers
- Gina Ogilvie and Manish Sadarangani: 6 shared papers
- Mark Loeb and Shelly McNeil: 5 shared papers
- Deborah Money and Shelly McNeil: 4 shared papers
- Shelly McNeil and Mel Krajden: 4 shared papers
- Shelly McNeil and Andrew Simor: 4 shared papers
- Mark Loeb and Joanne Langley: 3 shared papers
- Mark Loeb and Tamàs Fulop: 3 shared papers
- Mark Loeb and Janet McElhaney: 3 shared papers
- Philip Devereaux and Jonathan Bramson: 3 shared papers
- Stephen Walter and Jonathan Bramson: 3 shared papers
- Scott Halperin and Manish Sadarangani: 3 shared papers
- Shelly McNeil and Joanne Langley: 3 shared papers
- Shelly McNeil and Allison McGeer: 3 shared papers
- Joanne Langley and Allison McGeer: 3 shared papers
- Tobias Kollmann and Manish Sadarangani: 3 shared papers
- Andrew Simor and Jennie Johnstone: 3 shared papers
- Mark Loeb and Scott Halperin: 2 shared papers
- Philip Devereaux and Shelly McNeil: 2 shared papers
- Philip Devereaux and Tamàs Fulop: 2 shared papers
- Stephen Walter and Shelly McNeil: 2 shared papers
- Stephen Walter and Tamàs Fulop: 2 shared papers
- Jonathan Bramson and Shelly McNeil: 2 shared papers
- Deborah Money and Tobias Kollmann: 2 shared papers
- Scott Halperin and Shelly McNeil: 2 shared papers
- Shelly McNeil and Brian Ward: 2 shared papers
- Shelly McNeil and Tobias Kollmann: 2 shared papers
- Shelly McNeil and Gina Ogilvie: 2 shared papers
- Shelly McNeil and Tamàs Fulop: 2 shared papers
- Shelly McNeil and Janet McElhaney: 2 shared papers
- Shelly McNeil and Manish Sadarangani: 2 shared papers
- Allison McGeer and Janet McElhaney: 2 shared papers
- Scott Halperin and Denis Leclerc: 1 shared paper
- Scott Halperin and Brian Ward: 1 shared paper
- Shelly McNeil and Christina Wolfson: 1 shared paper
- Shelly McNeil and Denis Leclerc: 1 shared paper
- Shelly McNeil and Brian Ward: 1 shared paper
- Shelly McNeil and Jennifer Isenor: 1 shared paper
- Shelly McNeil and Jacqueline McMillan: 1 shared paper
- Shelly McNeil and Christina Wolfson: 1 shared paper
- Shelly McNeil and Jennie Johnstone: 1 shared paper
- Shelly McNeil and Bahaa Abu-Raya: 1 shared paper
- Joanne Langley and Denis Leclerc: 1 shared paper
- Brian Ward and Manish Sadarangani: 1 shared paper
- Manish Sadarangani and Bahaa Abu-Raya: 1 shared paper
- Pediatrics
- Medicine
- Health Research Methods, Evidence, and Impact
- Pathology & Molecular Medicine
- Obstetrics and Gynecology
- Laboratory Medicine and Pathology
- Department of Laboratory Medicine and Pathobiology
- Other
Co-authors at Dalhousie University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Mark Loeb
Pathology & Molecular Medicine
5 shared papers, latest 2024
Andrew Simor
Faculty
4 shared papers, latest 2024
Mel Krajden
Laboratory Medicine and Pathology
4 shared papers, latest 2025
Deborah Money
Obstetrics and Gynecology
4 shared papers, latest 2020
Allison McGeer
Department of Laboratory Medicine and Pathobiology
3 shared papers, latest 2024
Joanne Langley
Pediatrics
3 shared papers, latest 2020
Tamàs Fulop
Pédiatrie
2 shared papers, latest 2017
Janet McElhaney
Faculty
2 shared papers, latest 2019
Brian Ward
Pediatrics
2 shared papers, latest 2012
Manish Sadarangani
Pediatrics
2 shared papers, latest 2025
Gina Ogilvie
School of Population and Public Health
2 shared papers, latest 2017
Tobias Kollmann
Microbiology and Immunology
2 shared papers, latest 2020
Scott Halperin
Pediatrics
2 shared papers, latest 2020
Philip Devereaux
Health Research Methods, Evidence, and Impact
2 shared papers, latest 2017
Stephen Walter
Health Research Methods, Evidence, and Impact
2 shared papers, latest 2017
Jonathan Bramson
Medicine
2 shared papers, latest 2017
Jun Wang
Microbiology and Immunology
1 shared papers, latest 2026
Tony Mazzulli
Department of Laboratory Medicine and Pathobiology
1 shared papers, latest 2017
Soren Gantt
Medical Microbiology and Infectious Diseases
1 shared papers, latest 2024
Jacqueline McMillan
Geriatrics
1 shared papers, latest 2022
Christina Wolfson
Faculty
1 shared papers, latest 2022
Jennie Johnstone
Clinical Public Health Division
1 shared papers, latest 2017
Bahaa Abu-Raya
Pediatrics
1 shared papers, latest 2026
Kathryn Suh
Department of Medicine
1 shared papers, latest 2015
Linda Dodds
Pediatrics
1 shared papers, latest 2014
Christina Wolfson
Medicine
1 shared papers, latest 2022
Larry William Chambers
Health Research Methods, Evidence, and Impact
1 shared papers, latest 2015
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.